Pengfei Jiang

1.4k citations
55 papers · 1.1k indexed · h-index 19
Topics
Retinal Diseases and Treatments (6 papers)Nanoplatforms for cancer theranostics (4 papers)Glioma Diagnosis and Treatment (3 papers)

In The Last Decade

Pengfei Jiang

48 papers receiving 1.1k citations

Peers

Pengfei Jiang
Comparison fields: 5 of 108
  • Molecular Biology 451
  • Biomedical Engineering 239
  • Cancer Research 224
  • Materials Chemistry 217
  • Oncology 137
Replace Karolien Castermans with:
Karolien Castermans Belgium
Shoucheng Ning United States
Bahar Yetkin-Arik Netherlands
P.M. Schaffer Germany
Yun Zhou China
Liwei Ma China
Heming Li China
Yi-Ping Yang Taiwan
Pengfei Jiang relative to Karolien Castermans Belgium Karolien Castermans's profile →
Citations per field
00.5×1.5×1.8×
Karolien Castermans · 1×
Citations per year

Countries citing papers authored by Pengfei Jiang

Since Specialization
Citations

This map shows the geographic impact of Pengfei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Jiang more than expected).

Fields of papers citing papers by Pengfei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Jiang. The network helps show where Pengfei Jiang may publish in the future.

Co-authorship network of co-authors of Pengfei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Jiang. A scholar is included among the top collaborators of Pengfei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Jiang. Pengfei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 0
6 9
7 7
8 14
9 5
10 5
11 16
12 17
13 1
14 17
15 28
16 19
17 92
18 12
19 21
20 82

About Pengfei Jiang

Pengfei Jiang is a scholar working on Ophthalmology, Cancer Research and Biochemistry, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (6 papers), Nanoplatforms for cancer theranostics (4 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (224 citations), Ophthalmology (95 citations) and Pharmaceutical Science (52 citations). Pengfei Jiang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Katelyn E. Swindle‐Reilly, Santosh Kesari, Ying S. Chao, Sandra Pastorino, Sandeep C. Pingle, Natsuko Nomura, Valentina Fogal, Rajesh Mukthavaram, Ila Sri Bharati and Taher Abbasi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026